发明名称 |
RANOLAZINE FOR ENHANCING INSULIN SECRETION. |
摘要 |
<p>The invention is directed to methods for enhancing endogenous insulin levels in a patient in need thereof which method comprises administering to the patient an insulin secretion-enhancing amount of racemic ranolazine or the R- or S-enantiomer of ranolazine. It is also directed to methods of treatment comprising racemic ranolazine or the R- or S-enantiomer of ranolazine for enhancing endogenous insulin levels in a patient in need thereof. It is also directed to a composition comprising an insulin secretion-enhancing amount of racemic ranolazine or the R- or S-enantiomer of ranolazine and at least one anti-diabetic agent.</p> |
申请公布号 |
MX2009010895(A) |
申请公布日期 |
2009.10.26 |
申请号 |
MX20090010895 |
申请日期 |
2008.04.11 |
申请人 |
CV THERAPEUTICS, INC. |
发明人 |
LUIZ BELARDINELLI;DEWAN ZENG;ARVINDER DHALLA;JOHN SHRYOCK;KWAN LEUNG |
分类号 |
A61K31/495;A61K45/06;A61P3/10;A61P5/50;A61P9/00 |
主分类号 |
A61K31/495 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|